Found: 152
Select item for more details and to access through your institution.
Decreased sAβPPβ, Aβ<sub>38</sub>, and Aβ<sub>40</sub> Cerebrospinal Fluid Levels in Frontotemporal Dementia.
- Published in:
- Journal of Alzheimer's Disease, 2011, v. 26, n. 3, p. 553, doi. 10.3233/JAD-2011-110515
- By:
- Publication type:
- Article
Diagnosis of Methionine/Valine Variant Creutzfeldt-Jakob Disease by Protein Misfolding Cyclic Amplification.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Proteomics Challenges for the Assessment of Synuclein Proteoforms as Clinical Biomarkers in Parkinson's Disease.
- Published in:
- Frontiers in Aging Neuroscience, 2022, v. 14, p. 1, doi. 10.3389/fnagi.2022.818606
- By:
- Publication type:
- Article
Prospective 25-year surveillance of prion diseases in France, 1992 to 2016: a slow waning of epidemics and an increase in observed sporadic forms.
- Published in:
- Eurosurveillance (15607917), 2023, v. 28, n. 50, p. 15, doi. 10.2807/1560-7917.ES.2023.28.50.2300101
- By:
- Publication type:
- Article
Repeated neurofilament light chain measurements did not capture Riluzole therapeutic effect in amyotrophic lateral sclerosis patients.
- Published in:
- CNS Neuroscience & Therapeutics, 2022, v. 28, n. 10, p. 1532, doi. 10.1111/cns.13894
- By:
- Publication type:
- Article
N‐homocysteinylation of tau and MAP1 is increased in autopsy specimens of Alzheimer's disease and vascular dementia.
- Published in:
- Journal of Pathology, 2019, v. 248, n. 3, p. 291, doi. 10.1002/path.5254
- By:
- Publication type:
- Article
Retrovirus infection strongly enhances scrapie infectivity release in cell culture.
- Published in:
- EMBO Journal, 2006, v. 25, n. 12, p. 2674, doi. 10.1038/sj.emboj.7601162
- By:
- Publication type:
- Article
Association of caffeine consumption with cerebrospinal fluid biomarkers in mild cognitive impairment and Alzheimer's disease: A BALTAZAR cohort study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 10, p. 6948, doi. 10.1002/alz.14169
- By:
- Publication type:
- Article
Associations between blood‐based biomarkers and other outcomes related to Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.083146
- By:
- Publication type:
- Article
Routes to standardisation for tau protein measurement in CSF.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.076172
- By:
- Publication type:
- Article
Can construct specification equations help us progress the biomarker‐cognition debate in dementia?
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.071436
- By:
- Publication type:
- Article
Different cutoffs definitions to evaluate the concordance between CSF Ab42 and Ab42/Ab40 across neurodegenerative diseases.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.064134
- By:
- Publication type:
- Article
Plasma Aβ42/Aβ40 ratio is independent of renal function.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 6, p. 2737, doi. 10.1002/alz.12949
- By:
- Publication type:
- Article
Plasma amyloid beta predicts conversion to dementia in subjects with mild cognitive impairment: The BALTAZAR study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 12, p. 2537, doi. 10.1002/alz.12613
- By:
- Publication type:
- Article
The NeuroMET project: Metrology and innovation for early diagnosis and accurate stratification of patients with neurodegenerative diseases.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.053655
- By:
- Publication type:
- Article
Plasma biomarkers for the AT(N) classification and for the detection of Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.050187
- By:
- Publication type:
- Article
MALDI‐TOF IP‐MS quantification of plasma amyloid peptides in Alzheimer's disease: Developing topics.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.047112
- By:
- Publication type:
- Article
Development of a primary calibrator and candidate reference method for metrological traceability of tau protein results: Biomarkers (non‐neuroimaging) / Method development and/or quality control.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.043036
- By:
- Publication type:
- Article
P4‐218: SEX DIFFERENCES IN CEREBROSPINAL FLUID NEUROFILAMENT LIGHT CHAIN LEVELS ARE CONSISTENT ACROSS COHORTS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1359, doi. 10.1016/j.jalz.2019.06.3881
- By:
- Publication type:
- Article
P2‐615: INNOVATIVE MEASUREMENTS FOR IMPROVED DIAGNOSIS AND MANAGEMENT OF NEURODEGENERATIVE DISEASES.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P861, doi. 10.1016/j.jalz.2019.06.3025
- By:
- Publication type:
- Article
O2‐09‐01: THE NATURAL HISTORY OF ALZHEIMER'S DISEASE IN DOWN SYNDROME.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P558, doi. 10.1016/j.jalz.2019.06.4499
- By:
- Publication type:
- Article
P1‐259: A POTENTIAL REFERENCE MEASUREMENT PROCEDURE FOR QUANTIFICATION OF α‐SYNUCLEIN IN CSF.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P338, doi. 10.1016/j.jalz.2019.06.814
- By:
- Publication type:
- Article
P3‐249: COMBINING MATHEMATICAL MODEL AND CATECHOLAMINE QUANTIFICATIONS TO SCREEN ALZHEIMER DISEASE FROM A SIMPLE BLOOD TEST.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1168, doi. 10.1016/j.jalz.2018.06.1608
- By:
- Publication type:
- Article
P2‐233: BETTER MEASUREMENT FOR IMPROVED DIAGNOSIS AND MANAGEMENT OF ALZHEIMER'S DISEASE: UPDATE ON THE EMPIR NEUROMET PROJECT.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P759, doi. 10.1016/j.jalz.2018.06.920
- By:
- Publication type:
- Article
Plasma amyloid levels within the Alzheimer's process and correlations with central biomarkers.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, n. 7, p. 858, doi. 10.1016/j.jalz.2018.01.004
- By:
- Publication type:
- Article
New Perspectives of Multiplex Mass Spectrometry Blood Protein Quantification on Microsamples in Biological Monitoring of Elderly Patients.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 8, p. 6989, doi. 10.3390/ijms24086989
- By:
- Publication type:
- Article
Deconstructing Alzheimer's Disease: How to Bridge the Gap between Experimental Models and the Human Pathology?
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 16, p. 8769, doi. 10.3390/ijms22168769
- By:
- Publication type:
- Article
Variation of human salivary alpha-amylase proteoforms in three stimulation models.
- Published in:
- Clinical Oral Investigations, 2020, v. 24, n. 1, p. 475, doi. 10.1007/s00784-019-03021-9
- By:
- Publication type:
- Article
Hypocretin and brain β-amyloid peptide interactions in cognitive disorders and narcolepsy.
- Published in:
- Frontiers in Aging Neuroscience, 2014, v. 6, p. 1, doi. 10.3389/fnagi.2014.00119
- By:
- Publication type:
- Article
Hypocretin and brain β-amyloid peptide interactions in cognitive disorders and narcolepsy.
- Published in:
- Frontiers in Aging Neuroscience, 2014, v. 6, p. 1, doi. 10.3389/fnagi.2014.00119
- By:
- Publication type:
- Article
Cerebrospinal fluid A beta 1–40 peptides increase in Alzheimer's disease and are highly correlated with phospho-tau in control individuals.
- Published in:
- Alzheimer's Research & Therapy, 2020, v. 12, n. 1, p. N.PAG, doi. 10.1186/s13195-020-00696-1
- By:
- Publication type:
- Article
Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer's disease and PET amyloid-positive patient identification.
- Published in:
- Alzheimer's Research & Therapy, 2020, v. 12, n. 1, p. 1, doi. 10.1186/s13195-020-00596-4
- By:
- Publication type:
- Article
Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer's Disease.
- Published in:
- Alzheimer's Research & Therapy, 2019, v. 11, n. 1, p. N.PAG, doi. 10.1186/s13195-019-0485-0
- By:
- Publication type:
- Article
White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translation.
- Published in:
- Alzheimer's Research & Therapy, 2018, v. 10, p. 1, doi. 10.1186/s13195-018-0359-x
- By:
- Publication type:
- Article
Quantitative detection of amyloid-ß peptides by mass spectrometry: state of the art and clinical applications.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2015, v. 53, n. 10, p. 1483, doi. 10.1515/cclm-2014-1048
- By:
- Publication type:
- Article
Analytical challenges related to the use of biomarker ratios for the biological diagnosis of Alzheimer's disease.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2015, v. 53, n. 8, p. e175, doi. 10.1515/cclm-2014-1232
- By:
- Publication type:
- Article
Development and validation of dried matrix spot sampling for the quantitative determination of amyloid β peptides in cerebrospinal fluid.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2014, v. 52, n. 5, p. 649, doi. 10.1515/cclm-2013-0611
- By:
- Publication type:
- Article
Current and future use of 'dried blood spot' analyses in clinical chemistry.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2013, v. 51, n. 10, p. 1897, doi. 10.1515/cclm-2013-0228
- By:
- Publication type:
- Article
Performance evaluation of human cytokines profiles obtained by various multiplexed-based technologies underlines a need for standardization.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2013, v. 51, n. 7, p. 1385, doi. 10.1515/cclm-2012-0648
- By:
- Publication type:
- Article
Quantitative Clinical Chemistry Proteomics (qCCP) using mass spectrometry: general characteristics and application.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2013, v. 51, n. 5, p. 919, doi. 10.1515/cclm-2012-0723
- By:
- Publication type:
- Article
From 'Clinical Proteomics' to 'Clinical Chemistry Proteomics': considerations using quantitative mass-spectrometry as a model approach.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2012, v. 50, n. 2, p. 235, doi. 10.1515/cclm.2011.744
- By:
- Publication type:
- Article
Protein biochip systems for the clinical laboratory.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2005, v. 43, n. 12, p. 1291, doi. 10.1515/CCLM.2005.223
- By:
- Publication type:
- Article
Elevated plasma cysteinylglycine levels caused by cilastatin-associated antibiotic treatment.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2005, v. 43, n. 3, p. 332, doi. 10.1515/CCLM.2005.057
- By:
- Publication type:
- Article
Multiplexed LC‐MS/MS quantification of salivary RNA modifications in periodontitis.
- Published in:
- Journal of Periodontal Research, 2023, v. 58, n. 5, p. 959, doi. 10.1111/jre.13155
- By:
- Publication type:
- Article
Vers un diagnostic biologique sanguin de la maladie d'Alzheimer ?
- Published in:
- Médecine Sciences, 2024, v. 40, n. 4, p. 351, doi. 10.1051/medsci/2024037
- By:
- Publication type:
- Article
Les neurofilaments : un nouveau biomarqueur clé pour les cliniciens. Partie 2 : Neurofilaments, un intérêt au-delà des maladies neurodégénératives.
- Published in:
- Annales de Biologie Clinique, 2022, v. 80, n. 5, p. 441, doi. 10.1684/abc.2022.1758
- By:
- Publication type:
- Article
Les neurofilaments : un nouveau biomarqueur clé pour les cliniciens. Partie 1 : Intérêt des neurofilaments dans la prise en charge des maladies neurodégénératives.
- Published in:
- Annales de Biologie Clinique, 2022, v. 80, n. 5, p. 431, doi. 10.1684/abc.2022.1757
- By:
- Publication type:
- Article
SARS-CoV-2 et atteintes neurologiques : quelle est la place des biomarqueurs ?
- Published in:
- Annales de Biologie Clinique, 2021, v. 79, n. 1, p. 7, doi. 10.1684/abc.2021.1622
- By:
- Publication type:
- Article
Cellules souches dentaires : mythe ou espoir en médecine neurorégénératrice ?
- Published in:
- Annales de Biologie Clinique, 2020, v. 78, n. 6, p. 593, doi. 10.1684/abc.2020.1611
- By:
- Publication type:
- Article
L'hepcidine : caractéristiques immunoanalytiques.
- Published in:
- Annales de Biologie Clinique, 2018, v. 76, n. 6, p. 705, doi. 10.1684/abc.2018.1382
- By:
- Publication type:
- Article